免疫规避影响癌症进化过程中驱动基因的景观
Lucie Gourmet1,2, Andrea Sottoriva3,4, Simon Walker-Samuel2
1Department of Genetics, Evolution and Environment, UCL Genetics Institute, University College London, London, UK.
Genome biology
|June 26, 2024
概括
这项研究揭示了瘤中独特的癌症驱动基因,这些基因逃避免疫系统. 了解这些免疫逃生机制对于开发新的癌症疗法和改善患者分层至关重要.
科学领域:
- 在瘤学瘤学.
- 癌症基因组学 癌症基因组学
- 免疫学 免疫学 免疫学
背景情况:
- 癌症发生涉及遗传突变和瘤微环境之间的复杂相互作用.
- 以前的研究发现了癌症驱动基因,但往往忽视了免疫系统的影响和瘤异质性.
研究的目的:
- 为了比较驱动基因风景在瘤和没有免疫系统逃避.
- 研究免疫逃逸对驱动基因选择和瘤特征的影响.
主要方法:
- 来自"癌症基因组图谱"的9896种原发性瘤的分析.
- 利用非同义词与同义词突变比率 (dN/dS) 来识别驱动基因.
- 在免疫逃逸 (逃逸+) 和非逃逸 (逃逸-) 瘤之间比较驱动基因配置文件.
主要成果:
- 确定了85个驱动基因,包括27个新型基因在逃生瘤和16个新型基因在逃生+瘤.
- 在免疫逃逸瘤的驱动基因中观察到显著较低的dN/dS比率,表明选择缓冲.
- 发现免疫逃避与突变负担增加,突变特征多样化以及影响瘤预后有关.
结论:
- 免疫逃生影响癌症驱动基因的景观.
- 基于免疫逃避状态的患者分层可能会揭示新的治疗点.
- 需要进一步的研究来利用这些发现来改进癌症治疗策略.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510


